Literature DB >> 24900684

Design, Synthesis, and Pharmacological Evaluation of Fluorescent and Biotinylated Antagonists of ρ1 GABAC Receptors.

Navnath Gavande1, Hye-Lim Kim1, Munikumar R Doddareddy1, Graham A R Johnston2, Mary Chebib1, Jane R Hanrahan1.   

Abstract

The ρ1 GABAC receptor is a ligand-gated chloride ion channel that shows promise as a therapeutic target for myopia, sleep disorders, memory and learning facilitation, and anxiety-related disorders. As such, there is a need for molecular probes to understand the role GABAC receptors play in physiological and pathological processes. To date, no labeled (either radioactive or fluorescent) GABAC selective ligand has been developed that can act as a marker for GABAC receptor visualization and localization studies. Herein, we report a series of fluorescent ligands containing different-sized linkers and fluorophores based around (S)-4-ACPBPA [(4-aminocyclopenten-1-yl)-butylphosphinic acid], a selective GABAC antagonist. One of these conjugates, (S)-4-ACPBPA-C5-BODIPY (13), displayed moderate potency (IC50 = 58.61 μM) and selectivity (>100 times) for ρ1 over α1β2γ2L GABAA receptors. These conjugates are novel lead agents for the development of more potent and selective fluorescent probes for studying the localization and function of GABAC receptors in living cells.

Entities:  

Keywords:  CNS-related disorders; GABAC antagonists; Human ρ1 GABAC receptors; fluorescent and biotinylated probes; homology modeling and docking

Year:  2013        PMID: 24900684      PMCID: PMC4027487          DOI: 10.1021/ml300476v

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  30 in total

Review 1.  GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology.

Authors:  M Chebib; G A Johnston
Journal:  J Med Chem       Date:  2000-04-20       Impact factor: 7.446

2.  Mapping the antagonist binding site of the serotonin type 3 receptor by fluorescence resonance energy transfer.

Authors:  P Vallotton; A P Tairi; T Wohland; K Friedrich-Bénet; H Pick; R Hovius; H Vogel
Journal:  Biochemistry       Date:  2001-10-16       Impact factor: 3.162

3.  A molecular basis for agonist and antagonist actions at GABA(C) receptors.

Authors:  Heba Abdel-Halim; Jane R Hanrahan; David E Hibbs; Graham A R Johnston; Mary Chebib
Journal:  Chem Biol Drug Des       Date:  2008-02-28       Impact factor: 2.817

4.  BODIPY dyes and their derivatives: syntheses and spectroscopic properties.

Authors:  Aurore Loudet; Kevin Burgess
Journal:  Chem Rev       Date:  2007-10-09       Impact factor: 60.622

5.  Fluorescent labeling of NK2 receptor at specific sites in vivo and fluorescence energy transfer analysis of NK2 ligand-receptor complexes.

Authors:  G Turcatti; K Nemeth; M D Edgerton; J Knowles; H Vogel; A Chollet
Journal:  Receptors Channels       Date:  1997

Review 6.  Fluorescent ligands for the study of receptors.

Authors:  J C McGrath; S Arribas; C J Daly
Journal:  Trends Pharmacol Sci       Date:  1996-11       Impact factor: 14.819

7.  Discovering ligand-receptor interactions.

Authors:  Sarah A Slavoff; Alan Saghatelian
Journal:  Nat Biotechnol       Date:  2012-10       Impact factor: 54.908

8.  Novel Cyclic Phosphinic Acids as GABAC ρ Receptor Antagonists: Design, Synthesis, and Pharmacology.

Authors:  Navnath Gavande; Izumi Yamamoto; Noeris K Salam; Tu-Hoa Ai; Peter M Burden; Graham A R Johnston; Jane R Hanrahan; Mary Chebib
Journal:  ACS Med Chem Lett       Date:  2010-10-19       Impact factor: 4.345

Review 9.  Genetically engineered avidins and streptavidins.

Authors:  O H Laitinen; V P Hytönen; H R Nordlund; M S Kulomaa
Journal:  Cell Mol Life Sci       Date:  2006-12       Impact factor: 9.261

10.  Structural determinants for antagonist pharmacology that distinguish the rho1 GABAC receptor from GABAA receptors.

Authors:  Jianliang Zhang; Fenqin Xue; Yongchang Chang
Journal:  Mol Pharmacol       Date:  2008-07-03       Impact factor: 4.436

View more
  5 in total

1.  Application of High-Throughput Competition Experiments in the Development of Aspartate-Directed Site-Selective Modification of Tyrosine Residues in Peptides.

Authors:  Alex J Chinn; Jaeyeon Hwang; Byoungmoo Kim; Craig A Parish; Shane W Krska; Scott J Miller
Journal:  J Org Chem       Date:  2020-07-02       Impact factor: 4.354

2.  Argininamide-type neuropeptide Y Y1 receptor antagonists: the nature of N ω-carbamoyl substituents determines Y1R binding mode and affinity.

Authors:  Jonas Buschmann; Theresa Seiler; Günther Bernhardt; Max Keller; David Wifling
Journal:  RSC Med Chem       Date:  2020-01-20

3.  Multicomponent reactions for de novo synthesis of BODIPY probes: in vivo imaging of phagocytic macrophages.

Authors:  Ana Vázquez-Romero; Nicola Kielland; María J Arévalo; Sara Preciado; Richard J Mellanby; Yi Feng; Rodolfo Lavilla; Marc Vendrell
Journal:  J Am Chem Soc       Date:  2013-10-16       Impact factor: 15.419

4.  Synthesis and biochemical evaluation of cephalosporin analogues equipped with chemical tethers.

Authors:  Lisa M Miller; Reyme Herman; Ivan Gyulev; Thomas F Krauss; Gavin H Thomas; Anne-Kathrin Duhme-Klair
Journal:  RSC Adv       Date:  2020-10-02       Impact factor: 4.036

5.  Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications.

Authors:  Laura Goracci; Jenny Desantis; Aurora Valeri; Beatrice Castellani; Michela Eleuteri; Gabriele Cruciani
Journal:  J Med Chem       Date:  2020-10-07       Impact factor: 7.446

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.